1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
1859 operates in biotechnology, health care, product research, therapeutics based in Greater San Diego Area, West Coast, Western US, founded in 2019.
The company sits in the biotechnology, health care, product research, therapeutics segment, where it competes on its core product or service.
Its base of operations is Greater San Diego Area, West Coast, Western US.
The company is listed at the Series_A stage of development.
The company reports a headcount in the c_00051_00100 range.
It has disclosed roughly $52.2M in funding.
| Sector | Biotechnology, Health Care, Product Research, Therapeutics |
|---|---|
| Headquarters | Greater San Diego Area, West Coast, Western US |
| Country | US |
| Founded | 2019 |
| Employees | c_00051_00100 |
| Stage | series_a |
| Total funding | $52,213,740 |
Website: 1859.ai
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account